BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer - ScienceDirect
Bcl-xL (54H6) Rabbit mAb | Cell Signaling Technology
Bcl-XL Inhibits Membrane Permeabilization by Competing with Bax | PLOS Biology
BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells | Cell Death & Disease
Bcl-XL Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
Bcl-xL Antibody | Cell Signaling Technology
Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy | ACS Nano
Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation | Journal of Experimental & Clinical Cancer Research | Full Text
BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells | Cell Death & Disease
Honokiol modulates Bax/Bcl-2 and Bax/Bcl-xL ratio in human pancreatic... | Download Scientific Diagram
Metabolic Regulation of Protein N-Alpha-Acetylation by Bcl-xL Promotes Cell Survival: Cell
Bcl‐xL sequesters its C‐terminal membrane anchor in soluble, cytosolic homodimers | The EMBO Journal
BCL-XL
Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation | Journal of Experimental & Clinical Cancer Research | Full Text
SignalSilence® Bcl-xL siRNA I | Cell Signaling Technology
Bcl-xL stimulates Bax relocation to mitochondria and primes cells to ABT-737 - ScienceDirect
IJMS | Free Full-Text | Bcl-xL as a Modulator of Senescence and Aging
E2F1 interacts with BCL‐xL and regulates its subcellular localization dynamics to trigger cell death | EMBO reports
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance - ScienceDirect
Discovery of a Novel BCL-XL PROTAC Degrader with Enhanced BCL-2 Inhibition | Journal of Medicinal Chemistry
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease
Bcl-xL Antibody (H-5) | SCBT - Santa Cruz Biotechnology
